Company news

OPKO Health, Inc. news in 2025

OPKO Health, Inc.'s news releases, calls and decks from 2025, newest first.

View company

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 18, 2025

OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications

October 28, 2025

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

October 28, 2025

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers

October 27, 2025

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

October 21, 2025

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

September 15, 2025

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

July 30, 2025

OPKO Health to Report Second Quarter 2025 Financial Results on July 31

July 23, 2025

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress

July 7, 2025

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

June 24, 2025

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

June 24, 2025

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

June 8, 2025

OPKO Health to Participate in Two Upcoming Investor Conferences

May 14, 2025

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

April 29, 2025

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025

April 16, 2025

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

April 3, 2025

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

March 16, 2025

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

February 26, 2025

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025

February 12, 2025

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 8, 2025

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

January 6, 2025

Calls in 2025

Decks in 2025